MORBIDLY ADHERENT PLACENTA IN PATIENTS WITH PLACENTA PREVIA AND FETO-MATERNAL OUTCOMES
Main Article Content
Keywords
Morbidly adherent placenta, placenta previa, feto-maternal outcomes
Abstract
Background: Morbidly adherent placenta (MAP) is a severe obstetric complication characterized by the excessive attachment of the placenta to the uterine wall. Placenta accreta, placenta increta, and placenta percreta are different diseases that fall within a spectrum.
Aim: the objective of this research was to ascertain the prevalence of MAP in patients diagnosed with placenta previa and assess its influence on both foetal and maternal outcomes.
Study Design: Descriptive case series
Duration and Place of the Study: This study was conducted at the Department of Obstetrics and Gynecology, Rehman Medical Institute, Peshawar, from July 2022 to June 2023.
Material and Methods: The research sample consisted of 58 pregnant women who were diagnosed with placenta previa and previously had a caesarean surgery. The research excluded patients with a prior history of uterine surgery excluding caesarean section and multiple pregnancies. Fetomaternal outcomes were noted.
Results: Mean age of patients was 32.5 ± 4.6 years. The prevalence of MAP in patients with placenta previa was shown to be 17.2%. A majority of the patients (72.4%) were multiparous. 86.2% of patients had painless vaginal bleeding as the most frequent first symptom. The average gestational age at the time of diagnosis was 32.6 ± 2.8 weeks. Postpartum hemorrhage was observed in 41.4% patients and perinatal mortality was 17.2%.
Conclusion: The prevalence of MAP in patients with placenta previa is substantial and it is linked to significant feto-maternal complications and mortality. Prompt identification and appropriate treatment are essential for enhancing outcomes for both the mother and the newborn.
References
2. Lu D. Prenatal diagnosis of placenta previa complicated by placenta percreta. Journal of Diagnostic Medical Sonography. 2019 Jan;35(1):70-3.
3. Singh R, Pradeep Y. Maternal and neonatal outcomes in morbidly adherent placenta: a developing country experience. Tropical Doctor. 2015 Jul;45(3):183-7.
4. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. The journal of maternal-fetal & neonatal medicine. 2003 Jan 1;13(3):175-90.
5. Jain V, Bos H, Bujold E. Guideline No. 402: diagnosis and management of placenta previa. Journal of Obstetrics and Gynaecology Canada. 2020 Jul 1;42(7):906-17.
6. Channana P. To examine the association between placenta previa and its impact on maternal and foetal outcomes. Int J Acad Med Pharm. 2023;5(4):2095-100.
7. Timor‐Tritsch IE, Monteagudo A, Cali G, Vintzileos A, Viscarello R, Al‐Khan A, et al. Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound in Obstetrics & Gynecology. 2014 Sep;44(3):346-53.
8. Garofalo A, Pilloni E, Alemanno MG, Garofalo G, Sciarrone A, Todros T, et al. Ultrasound accuracy in prenatal diagnosis of abnormal placentation of posterior placenta previa. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2019 Nov 1;242:86-91.
9. AbdRabbo SA. Stepwise uterine devascularization: a novel technique for management of uncontrollable postpartum hemorrhage with preservation of the uterus. American journal of obstetrics and gynecology. 1994 Sep 1;171(3):694-700.
10. Anorlu RI, Maholwana B, Hofmeyr GJ. Methods of delivering the placenta at caesarean section. Cochrane Database of Systematic Reviews. 2008(3).
11. Shi J, Dai Y, Zhang J, Li X, Jia S, Leng J. Pregnancy outcomes in women with infertility and coexisting endometriosis and adenomyosis after laparoscopic surgery: a long-term retrospective follow-up study. BMC Pregnancy and Childbirth. 2021 Dec;21(1):1-9.
12. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World Journal of Gastroenterology. 2003 Oct 10;9(10):2300.
13. Rao KP, Belogolovkin V, Yankowitz J, Spinnato JA. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa. Obstetrical & gynecological survey. 2012 Aug 1;67(8):503-19.
14. Madazli R, Yuksel MA, Oncul M, Tuten A, Guralp O, Aydin B. Pregnancy outcomes and prognostic factors in patients with intrahepatic cholestasis of pregnancy. Journal of Obstetrics and Gynaecology. 2015 May 19;35(4):358-61.
15. Jaraquemada JP, Bruno CH, Clavelli WA. Morbid adherent placenta: prediction, diagnosis and management. Fetal and Maternal Medicine Review. 2007 Nov;18(4):357-81.
16. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesthesia & Analgesia. 2007 Dec 1;105(6):1736-40.
17. Bang RA, Bang AT, Reddy MH, Deshmukh MD, Baitule SB, Filippi V. Maternal morbidity during labour and the puerperium in rural homes and the need for medical attention: a prospective observational study in Gadchiroli, India. BJOG: An international journal of Obstetrics & Gynaecology. 2004 Mar;111(3):231-8.
18. Nakimuli A, Mbalinda SN, Nabirye RC, Kakaire O, Nakubulwa S, Osinde MO, et al. Still births, neonatal deaths and neonatal near miss cases attributable to severe obstetric complications: a prospective cohort study in two referral hospitals in Uganda. BMC pediatrics. 2015 Dec; 15:1-8.
19. Kim JH, Lee SM, Lee YH. Risk factors for respiratory distress syndrome in full-term neonates. Yeungnam University journal of medicine. 2018 Dec 31;35(2):187-91.
20. Zwart JJ, Richters JM, Öry F, De Vries JI, Bloemenkamp KW, Van Roosmalen J. Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population‐based study of 371 000 pregnancies. BJOG: An International Journal of Obstetrics & Gynaecology. 2008 Jun;115(7):842-50.